Fidelity Investments
MRVI icon

Fidelity Investments’s Maravai LifeSciences MRVI Stock Holding History

Fidelity Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
34,133
-946
-3% -$4.08K ﹤0.01% 3636
2026
Q1 		$99.3K Sell
35,079
-230
-0.7% -$780 ﹤0.01% 3799
2025
Q4 		$115K Buy
35,309
+1,939
+6% +$6.53K ﹤0.01% 3691
2025
Q3 		$95.8K Buy
33,370
+7,047
+27% +$18K ﹤0.01% 3681
2025
Q2 		$63.4K Sell
26,323
-15,047
-36% -$31.6K ﹤0.01% 3787
2025
Q1 		$91.4K Sell
41,370
-2,088,081
-98% -$8.25M ﹤0.01% 3597
2024
Q4 		$11.6M Sell
2,129,451
-349,784
-14% -$2.25M ﹤0.01% 1890
2024
Q3 		$20.6M Sell
2,479,235
-159,159
-6% -$1.38M ﹤0.01% 1696
2024
Q2 		$18.9M Buy
2,638,394
+2,083,301
+375% +$18M ﹤0.01% 1675
2024
Q1 		$4.81M Buy
555,093
+97,885
+21% +$662K ﹤0.01% 2089
2023
Q4 		$2.99M Buy
457,208
+450,379
+6,595% +$2.91M ﹤0.01% 2214
2023
Q3 		$68.3K Buy
6,829
+1,237
+22% +$13.6K ﹤0.01% 3247
2023
Q2 		$69.5K Sell
5,592
-967,663
-99% -$13.1M ﹤0.01% 3302
2023
Q1 		$13.6M Buy
973,255
+878,476
+927% +$12.6M ﹤0.01% 1761
2022
Q4 		$1.36M Sell
94,779
-2,432,900
-96% -$38.3M ﹤0.01% 2475
2022
Q3 		$64.5M Sell
2,527,679
-1,480,224
-37% -$37.1M 0.01% 1137
2022
Q2 		$114M Sell
4,007,903
-5,432,087
-58% -$172M 0.01% 924
2022
Q1 		$333M Sell
9,439,990
-3,267,656
-26% -$110M 0.03% 584
2021
Q4 		$532M Sell
12,707,646
-5,179,650
-29% -$210M 0.04% 440
2021
Q3 		$878M Buy
17,887,296
+5,235,025
+41% +$255M 0.07% 260
2021
Q2 		$528M Buy
12,652,271
+2,949,028
+30% +$114M 0.04% 408
2021
Q1 		$346M Buy
9,703,243
+3,996,681
+70% +$132M 0.03% 568
2020
Q4 		$160M Buy
+5,706,562
New +$159M 0.01% 840

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Fidelity Investments's MRVI Position: Q2 2026 in Review

Fidelity Investments reduced its Maravai LifeSciences (MRVI) stake by 2.7% in Q2 2026, selling an estimated $4.08K and leaving 34,133 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

Fidelity Investments first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $878M in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Fidelity Investments held 34,133 shares of Maravai LifeSciences worth $213K as of Q2 2026.
  • Fidelity Investments sold 946 Maravai LifeSciences shares in Q2 2026, an estimated $4.08K.
  • Maravai LifeSciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3636 holding.
  • Fidelity Investments first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • Fidelity Investments's Maravai LifeSciences position peaked at $878M in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.